Meeder Asset Management’s Crinetics Pharmaceuticals CRNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.82K | Buy |
98
+34
| +53% | +$978 | ﹤0.01% | 785 |
|
|
2025
Q1 | $2.15K | Sell |
64
-17
| -21% | -$570 | ﹤0.01% | 863 |
|
|
2024
Q4 | $4.14K | Buy |
81
+5
| +7% | +$256 | ﹤0.01% | 853 |
|
|
2024
Q3 | $3.88K | Buy |
+76
| New | +$3.88K | ﹤0.01% | 782 |
|
|
2021
Q4 | – | Sell |
-1,988
| Closed | -$42K | – | 1420 |
|
|
2021
Q3 | $42K | Buy |
+1,988
| New | +$42K | ﹤0.01% | 1143 |
|